Lotte & John Hecht Memorial Foundation
19
3
3
13
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
5.3%
1 terminated/withdrawn out of 19 trials
92.9%
+6.4% vs industry average
32%
6 trials in Phase 3/4
15%
2 of 13 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (19)
Pacing In Organ Donors (the POD Trial)
Role: collaborator
The Thoracic Peri-Operative Integrative Surgical Care Evaluation Trial - Stage III
Role: collaborator
Immersive Multimedia as an Adjunctive Measure for Pain Control in Cancer Patients
Role: collaborator
The Thoracic Peri-Operative Integrative Surgical Care Evaluation (POISE) Trial- Stage I
Role: collaborator
Perinatal Depression & Anxiety (PDA) and Maternal Gut Microbiome
Role: collaborator
Transcranial Magnetic Stimulation for Psychological Distress in Patients With Advanced Illness
Role: collaborator
A Placebo Controlled Study of Homeopathic Treatment of Children and Youth With ADHD
Role: collaborator
The Canadian/US Integrative Oncology Study
Role: collaborator
Lessening Organ Dysfunction With VITamin C - COVID-19
Role: collaborator
Lessening Organ Dysfunction With VITamin C
Role: collaborator
Adjuvant Melatonin for Prevention of Lung Cancer Recurrence and Mortality
Role: collaborator
Efficacy and Safety of Omega 3 Fatty Acid Supplements on Heavy Smokers
Role: collaborator
New Treatment Option for Pancreatic Cancer
Role: collaborator
Integrative Oncology Outcomes Study in Breast Cancer
Role: collaborator
Pediatric Integrative Medicine Trial Pilot
Role: collaborator
High Dose Vitamin D Study
Role: collaborator
Study of POMELLA™ Extract to Treat Prostate Cancer
Role: collaborator
Siliphos in Advanced Hepatocellular Carcinoma
Role: collaborator
Orthomolecular Therapy and Asthma in Children
Role: collaborator
All 19 trials loaded